Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease: A LoDoCo2 Proteomic Substudy
- PMID: 32864998
- DOI: 10.1161/CIRCULATIONAHA.120.050560
Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease: A LoDoCo2 Proteomic Substudy
Keywords: atherosclerosis; colchicine; coronary artery disease; inflammasomes; inflammation.
Comment in
-
Colchicine for Secondary Cardiovascular Prevention in Coronary Disease.Circulation. 2020 Nov 17;142(20):1901-1904. doi: 10.1161/CIRCULATIONAHA.120.051240. Epub 2020 Nov 16. Circulation. 2020. PMID: 33196312 No abstract available.
Similar articles
-
Atherosclerosis imaging and circulating blood biomarkers: insights into subclinical atherosclerotic plaque burden and disease activity.Int J Cardiovasc Imaging. 2005 Aug;21(4):443-5. doi: 10.1007/s10554-005-0765-6. Int J Cardiovasc Imaging. 2005. PMID: 16047126 No abstract available.
-
Serum metalloproteinase 9 levels in patients with coronary artery disease: a novel marker of inflammation.J Investig Med. 2003 Sep;51(5):295-300. doi: 10.1136/jim-51-05-17. J Investig Med. 2003. PMID: 14577520
-
Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive protein.PLoS One. 2020 Aug 31;15(8):e0237665. doi: 10.1371/journal.pone.0237665. eCollection 2020. PLoS One. 2020. PMID: 32866166 Free PMC article. Clinical Trial.
-
Newer risk markers and surrogate endpoints in atherosclerosis management.Clin Cardiol. 2001 Aug;24(8 Suppl):III13-7. doi: 10.1002/clc.4960241504. Clin Cardiol. 2001. PMID: 11501598 Free PMC article. Review.
-
The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.Atherosclerosis. 2018 Feb;269:262-271. doi: 10.1016/j.atherosclerosis.2017.12.027. Epub 2017 Dec 25. Atherosclerosis. 2018. PMID: 29352570 Review.
Cited by
-
COVID-19 in the Initiation and Progression of Atherosclerosis: Pathophysiology During and Beyond the Acute Phase.JACC Adv. 2024 Jul 17;3(8):101107. doi: 10.1016/j.jacadv.2024.101107. eCollection 2024 Aug. JACC Adv. 2024. PMID: 39113913 Free PMC article. Review.
-
Studying the efficacy of low-dose colchicine on clinical outcomes of patients with STEMI: a randomized controlled trial.Egypt Heart J. 2024 Jul 5;76(1):85. doi: 10.1186/s43044-024-00515-0. Egypt Heart J. 2024. PMID: 38969838 Free PMC article.
-
Low-Dose Colchicine Ameliorates Doxorubicin Cardiotoxicity Via Promoting Autolysosome Degradation.J Am Heart Assoc. 2024 May 7;13(9):e033700. doi: 10.1161/JAHA.123.033700. Epub 2024 May 3. J Am Heart Assoc. 2024. PMID: 38700005 Free PMC article.
-
A systematic review on the use of Colchicine in Hemorrhagic Stroke.World Neurosurg X. 2024 Mar 18;23:100314. doi: 10.1016/j.wnsx.2024.100314. eCollection 2024 Jul. World Neurosurg X. 2024. PMID: 38549758 Free PMC article. Review. No abstract available.
-
Colchicine's Role in Cardiovascular Disease Management.Arterioscler Thromb Vasc Biol. 2024 May;44(5):1031-1041. doi: 10.1161/ATVBAHA.124.319851. Epub 2024 Mar 21. Arterioscler Thromb Vasc Biol. 2024. PMID: 38511324 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
